TENX
Tenax Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.88
+5.34%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-57.1%
Return on equity
-53.3%
Return on assets
-60.4%
Return on invested capital
0.00x
Asset turnover
-$46.0M
Cash from operations
$3.15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026